Cells for Cells participated in the Startups Latam 2022 report launch as a leader and…
tactech userApril 27, 2022
Cells for Cells and Universidad de los Andes were awarded the Fourth National Basal Funding…
tactech userNovember 17, 2021
Cells for Cells (C4C), a pioneering regenerative medicine company based in Santiago, Chile, received news…
tactech userOctober 19, 2021
Recent Posts
- ISCT highlights observations from major Chilean advanced therapy developer group on Latin American regulation for Regenerative Medicine products in its recent Telegraft issue
- Chile’s Ministry of Science recognizes Cells for Cells as university spin-off success case in white paper
- Cells for Cells treats the first-ever patient with an exosome-produced therapy for osteoarthritis
- Cells for Cells presented groundbreaking results of three extracellular vesicles products at ISCT and ISEV annual meetings
- Cells for Cells featured in Startups Latam’s 2022 report
